CXCR7 antagonist-1

CXCR7 antagonist-1 is a CXCR7 antagonist that inhibits the binding of the SDF-1 chemokine (also known as the CXCL12 chemokine) or I-TAC (also known as CXCL11) to the chemokine receptor CXCR7. CXCR7 antagonist-1 is useful in preventing tumor cell proliferation, tumor formation, inflammatory diseases, and many other diseases (extracted from patent WO2014085490A1, compound 1.128).


Cat. No.: EX-A6006	Purity: >98%

	Chemical structure of CXCR7 antagonist-1

For research only, Do not use for Human!

Size	Unit Price (US$)	Stock
10mg	500	In-stock
25mg	800	In-stock
50mg	1200	In-stock
100mg	1600	In-stock
500mg	3900	In-stock

Send PO to E-mail:[email protected]; or Fax:+86 020 81619670

Discount Request


CAS No.	1613021-99-0
Purity	>98%
Formula	C21H19FN6O
Mol Weight	390.4136
Color	Off-white to gray
State	solid powder
Solubility	Soluble in DMSO 100 mg/mL
Shelf Life	>3 years if stored properly
Storage	Powder 4℃, protect from light, 2 years; In solvent -20℃ 1 month;
Shipping	Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Reference:	[1]. Zhao C, et al., Infant RSV infection desensitizes β2-adrenergic receptor via CXCL11-CXCR7 signaling in airway smooth muscle. bioRxiv [Preprint]. 2025 Jan 15:2025.01.13.632772. [2]. Junfa Fan, et al. Cxcr7 antagonists. Patent WO2014085490A1.
CoA	CoA of CXCR7 antagonist-1


		Search